Atrial fibrillation: The nonpharmacologic strategy

Mount Sinai Journal of Medicine

Volumn 69, Issue 4, 2002, Pages 232-241

  Lee, Johnny ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Catheter ablation maze; Nonpharmacologic review management

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

BLOOD TOXICITY; CARDIOTOXICITY; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DIARRHEA; GASTROINTESTINAL TOXICITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART BLOCK; HEART CONDUCTION; HEART EJECTION FRACTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; MORTALITY; PALLIATIVE THERAPY; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SAFETY; SICK SINUS SYNDROME; SINUS RHYTHM; SURGICAL TECHNIQUE; TORSADE DES POINTES; TREATMENT PLANNING;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; PACEMAKER, ARTIFICIAL; PALLIATIVE CARE;

EID: 0036723690     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. New concepts in atrial defibrillation
2. New trials in atrial fibrillation
3. The atrial defibrillator: A stand-alone device or part of a combined dual-chamber system?
4. An 8 1/2-year clinical experience with surgery for atrial fibrillation
5. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
6. A focal source of atrial fibrillation treated by discrete radiofrequency ablation
7. A computer model of atrial fibrillation
8. Management of atrial fibrillation: The need for AFFIRMative action. AFFIRM investigators
9. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
10. The AFFIRM trial: Main trial and substudies - What can we expect?
11. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
12. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design
13. Drug choices in the treatment of atrial fibrillation
14. Antiarrhythmic agents for atrial fibrillation: Focus on prolonging atrial repolarization
15. Treatment strategies for atrial fibrillation
16. Current treatment recommendations in antiarrhythmic therapy
17. Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome
18. Pharmacological management of atrial fibrillation: An update
19. Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment
20. Is there a need for new antiarrhythmic drugs?
21. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation
22. Atrial fibrillation: A review of mechanism etiology, and therapy
23. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation
24. Treatment of postoperative atrial fibrillation: A nonsurgical perspective
25. Amiodarone to prevent recurrence of atrial fibrillation
26. Ibutilide: An antiarrhythmic agent for the treatment of atrial fibrillation or flutter
27. Ibutilide: A new class III antiarrhythmic agent
28. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation
29. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
30. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
31. Dofetilide: A review of its use in atrial fibrillation and atrial flutter
32. New approaches to the management of atrial fibrillation: The role of the atrial defibrillator
33. Intra-atrial defibrillation in humans
34. Atrial fibrillation: Current knowledge and recommendations for management
35. Atrioverter: An implantable device for the treatment of atrial fibrillation
36. Initial experience with a new dual chamber defibrillator in humans
37. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing
38. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome
39. Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block
40. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
41. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation
42. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study
43. Evolution of strategies in the non-pharmacologic management of atrial fibrillation: A review
44. A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation
45. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation
46. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation
47. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation
48. Atrioventricular junctional ablation and modification for atrial fibrillation
49. Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation
50. Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease
51. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram
52. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery
53. Novel catheter technology for ablative cure of atrial fibrillation